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A YptyRab effector complex containing the Sec1
homolog Vps33p is required for homotypic
vacuole fusion
Darren F. Seals, Gary Eitzen, Nathan Margolis, William T. Wickner*, and Albert Price†
Department of Biochemistry, Dartmouth Medical School, 7200 Vail Building, Hanover, NH 03755-3844
Contributed by William T. Wickner, June 16, 2000
Yeast vacuoles undergo priming, docking, and homotypic fusion,
although little has been known of the connections between these
reactions. Vacuole-associated Vam2p and Vam6p (Vam2y6p) are
components of a 65S complex containing SNARE proteins. Upon
priming by Sec18pyNSF and ATP, Vam2y6p is released as a 38S
subcomplex that binds Ypt7p to initiate docking. We now report
that the 38S complex consists of both Vam2y6p and the class C Vps
proteins [Reider, S. E. and Emr, S. D. (1997) Mol. Biol. Cell 8,
2307–2327]. This complex includes Vps33p, a member of the Sec1
family of proteins that bind t-SNAREs. We term this 38S complex
HOPS, for homotypic fusion and vacuole protein sorting. This
unexpected finding explains how Vam2y6p associates with
SNAREs and provides a mechanistic link of the class C Vps proteins
to YptyRab action. HOPS initially associates with vacuole SNAREs
in ‘‘cis’’ and, after release by priming, hops to Ypt7p, activating this
YptyRab switch to initiate docking.
The compartmentation of eukaryotic cells requires passage ofproteins between organelles by membrane vesicle budding
and fusion. Proteins synthesized at the endoplasmic reticulum
are partitioned into budding vesicles that fuse to the Golgi. The
process of budding, transport, and fusion continues to other
subcellular destinations including the plasma membrane and the
lysosome.
The yeast counterpart of the mammalian lysosome is the
vacuole. Several mutant screens have identified genes (VPS)
that function in vacuole protein sorting. One type of screen
(vps) exploited the aberrant secretion of vacuolar proteases
(1–3). Together with screens for altered vacuolar peptidase
activity (pep), vacuole inheritance (vac), and vacuole morphol-
ogy (vam), more than 40 complementation groups have been
identified (4–6). The VPS genes have been grouped into six
classes based on vacuole morphology, ranging from normal
vacuole appearance (class A) to multiple vacuoles (class B)
to cells containing highly fragmented vacuoles or no recog-
nizable vacuolar structures (class C) (7, 8). Many of the
proteins encoded by the VPS genes have been studied, and
their functions in vacuole transport pathways are being
elucidated (9).
We have studied the homotypic fusion of yeast vacuoles, the
last step in their inheritance to the bud during cell division.
This process is studied in vitro with a biochemical assay in
which vacuoles from a proteinase A-deficient strain (BJ3505,
pep4D) are mixed with vacuoles from a strain deleted in the
gene encoding the membrane-associated alkaline phosphatase
(DKY6281, pho8D) (10). Vacuole fusion allows Pep4p to gain
access to pro-Pho8p and process it to its catalytically active
form that can be assayed spectrophotometrically. Homotypic
vacuole fusion occurs in the obligately ordered subreactions of
priming, docking, and fusion. Priming is driven by hydrolysis of
ATP by Sec18p (yeast NSF) (11, 12). This triggers the release
of Sec17p (yeast a-SNAP) from the vacuole membrane and the
disassembly of a large cis-SNARE complex, which includes a
t-SNARE (Vam3p), three v-SNAREs (Nyv1p, Vti1p, and
Ykt6p), and a homolog of neuronal SNAP-25 (Vam7p) (12–
15). This SNARE disassembly is accompanied by the activa-
tion of Vam3p which, in turn, is stabilized by the chaperone
LMA1 (16–18). Priming is followed by a two-stage docking
event that brings the vacuoles into physical contact (19). The
first stage of docking is reversible and SNARE-independent,
requiring instead a small, Rab-like GTPase called Ypt7p (20).
The second stage, which is irreversible, involves trans-SNARE
complex formation between apposed vacuoles (19). Recently,
it was shown that phosphatidylinositol 4,5-biphosphate is
needed for both the priming and docking subreactions (21).
The final subreaction, that of vacuole fusion, depends on
calciumycalmodulin and protein phosphatase 1, leading to the
release of LMA1 (18, 22, 23).
We recently have studied two regulators of vacuole docking,
Vam2p (Vps41p) and Vam6p (Vps39p) (24, 25). vam2 and vam6
mutants have fragmented vacuoles like the ypt7 (vam4) mutant.
VAM2 and VAM6 are classified as class B VPS genes (6–8).
Approximately half of Vam2p and Vam6p is associated with
vacuoles, based on in vivo analysis of green fluorescent protein
fusion constructs and in vitro analysis of both fractionated cell
extracts and isolated, intact vacuoles (24, 26). Antibodies to
either Vam2p or Vam6p block the docking stage of in vitro
vacuole fusion, as seen for antibodies to Ypt7p (20). Vam2p and
Vam6p (Vam2y6p) initially are part of a large 65S protein
complex on the vacuole that includes Vam3p and Nyv1p. Priming
by Sec18p and ATP triggers complex disassembly. This priming-
dependent disassembly leads to a smaller, 38S Vam2y6p complex
that can associate with Ypt7p, thereby establishing Vam2y6p as
an essential physical and functional link between priming and
docking (24, 25).
We now report that the Vam2y6p complex also includes all
four proteins encoded by class C VPS genes: Vps11p (Vam1p),
Vps16p (Vam9p), Vps18p (Vam8p), and the Sec1p homolog
Vps33p (Vam5p). We term the complex that contains these six
proteins HOPS for homotypic vacuole fusion and vacuole pro-
tein sorting and to reflect the fact that it hops from one set of
associations to another. The HOPS complex initially is found in
a 65S complex with SNAREs before priming, is released without
SNAREs after priming, and thereby gains the capacity to
associate specifically with the GTP-bound form of Ypt7p. We
also show that antibodies to all four class C Vps proteins block
vacuole fusion, as seen previously for antibodies to Vam2p,
Vam6p, Ypt7p, and the SNAREs. The discovery that this HOPS
YptyRab effector complex contains Vps33p, a member of the
Sec1p family of proteins that bind t-SNAREs (27–29), provides
Abbreviations: HOPS, homotypic fusion and vacuole protein sorting; VPS, vacuole protein
sorting; VAM, vacuole morphology; GTP[gS], guanosine 59-[g-thio]triphosphate.
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clear, physical evidence for the long-sought link between Ypty
Rab function and SNAREs. Surprisingly, whereas most Rab
effectors are thought to bind to Rab proteins before SNAREs,
HOPS is transferred from cis-associated SNAREs to the Ypty
Rab by the priming action of Sec18pyNSF.
Materials and Methods
Vacuole Isolation. Vacuoles were isolated from yeast strains
BJ3505 and DKY6281 as described (30). Large-scale frozen
vacuole preparations of BJ3505 vacuoles were used for studies of
glutathione S-transferase (GST)-Ypt7p association and for im-
munoprecipitation experiments. Briefly, a 1-liter shaker culture
was grown to OD600 5 1.0 in 1% yeast extract, 2% Bacto-
peptone, and 2% dextrose (13 YPD) at 30°C and 225 rpm, added
to 5 liters of 13 YPD in a fermentor (New Brunswick Scientific),
and grown to an OD600 of ’7.0 at 30°C and 800-rpm agitation
with periodic supplementation of 53 YP, 50% dextrose, and 1
M NaOH to maintain adequate nutrient levels and the pH at 6.0.
Cells were harvested [4,400 3 g, 10 min, 4°C; JA-10 rotor
(Beckman)] and spheroplasted (30) except that postlysis cen-
trifugation was at 1,400 3 g for 5 min at 4°C (JA-14 rotor;
Beckman). Spheroplast pellets were resuspended in an equal
volume of PS buffer (10 mM Pipes, pH 6.8y200 mM sorbitol)
containing 8% (wtyvol) Ficoll and then lysed by dextran treat-
ment as described (30). Lysates were diluted with an equal
volume of PS buffer containing 4% (wtyvol) Ficoll and centri-
fuged [300,000 3 g, 1 h, 4°C; Type 60 Ti rotor (Beckman)].
Vacuoles were harvested from the top of the 4% Ficoll buffer,
diluted 5-fold with PS buffer, and centrifuged (15,000 3 g, 10
min, 4°C; JA-14 rotor). Vacuoles were resuspended at 0.3 mgyml
in PS buffer with 10% glycerol and frozen dropwise in liquid
nitrogen for long-term storage at 285°C.
GST-Tagged Class C Vps Protein Preparation. Polyclonal antibodies
were raised in rabbits against GST-tagged fusion proteins. DNA
fragments corresponding to the carboxyl-terminal portions of
Vps5p (289 aa), Vps11p (354 aa), Vsp16p (348 aa), Vps17p (552
aa), Vps18p (342 aa), Vps33p (225 aa), and Vps45p (578 aa) were
amplified by PCR from yeast genomic DNA by using the
following primers: VPS5 59 primer-CGC GGA TCC ACA AGT
GAT GAC TTT AGT TC, VPS5 39 primer-CGC GGA TCC
TAT TCA TTT TAC TTA CTG T; VPS11 59 primer-CGC GGA
TCC TTA GAA GCC TGT TTG GCA T, VPS11 39 primer-CGC
GGA TCC AAC ATG CGC TGT TTC AG; VPS16 59 primer-
CGC GGA TCC GGT AGT CCT GAC ATG GAA G, VPS16
39 primer-CGC GGA TCC TTC GCG TTC CAT GGG T;
VPS17 59 primer-CGC GGA TCC ATG ACT TCG GCT GTA
CCT, VPS17 39 primer-CGC GGA TCC GCA ACC ATT TTT
ATC TGT TAT; VPS18 59 primer-CGC GGA TCC AAT AAG
TTA ATT CCA ACA ATT TT, VPS18 39 primer-CGC GGA
TCC TAT TTA GGT AAG TAA ATA CTC; VPS33 59 primer-
CGC GGA TCC ATC GAC TCT TGG GGC ATT, VPS33 39
primer-CGC GGA TCC TCT AGA AAA TTA AAG GAT
ACA; and VPS45 59 primer-CGC GGA TCC ATG AAC CTT
TTT GAT GTG G, VPS45 39 primer-CGC GGA TCC ACG
CAT GCA CAT AGA AGG. DNA fragments were digested with
BamHI, purified and cloned into pGEX-4T-1 (Amersham Phar-
macia), and transformed into Escherichia coli BL21 (Strat-
agene). Transformants were examined for correct gene orien-
tation by diagnostic restriction enzyme digests and expression of
the fusion proteins. E. coli strains harboring fusion protein
constructs were grown at 37°C to an OD600 of 0.5. Protein
expression was induced by the addition of isopropyl b-D-
thiogalactoside to 1 mM, and cultures were incubated for 3 h.
Cells from a 3-liter culture were harvested at 700 3 g for 5 min
at 4°C (JA-10 rotor; Beckman), suspended in 120 ml of PBS (31),
centrifuged as above, and suspended in 120 ml of PBS. Cells then
were lysed by two freeze–thaw cycles, incubation with 0.1 mgyml
lysozyme for 10 min at room temperature, sonication (two times,
30 s each), and incubation with 1% Triton X-100 for 10 min at
4°C. Lysates were centrifuged at 10,000 3 g for 10 min at 4°C
(JA-20 rotor; Beckman); fusion proteins were found in the pellet.
Pellets were suspended in 120 ml of 50 mM citrate, adjusted to
pH 6.0 with solid Na2HPO4, for 30 min at room temperature and
centrifuged at 18,000 3 g for 10 min at 4°C (JA-20 rotor). Pellets
were suspended in 30 ml of 50 mM citrate buffer, pH 6.0,
containing 1.5% N-laroylsarcosine for 30 min at room temper-
ature and centrifuged at 48,000 3 g for 10 min at 4°C (JA-20
rotor). The Sarkosyl extracts, which contained the GST-tagged
class C Vps proteins, were dialyzed at 4°C for 36 h with three
changes of PBS containing 1.5% N-laroylsarcosine.
Antibody Purification. Polyclonal antibodies were raised in rabbits
to the GST-tagged class C Vps proteins or to peptides (CLE
DTE QWQ KDG FDL NSK KT and CIE DEH AAD KIT NEN
DDF SEA) from the Vps33p sequence. For purification, GST-
tagged class C Vps proteins or peptides were cross-linked to
Sulfolink Coupling Gel (Pierce) according to the manufacturer’s
instructions, except that 1.5% N-laroylsarcosine was included
during the postreduction gel-filtration step for the fusion pro-
teins. Antibodies were affinity-purified on the cognate antigen-
or peptide-Sulfolink column (32). Acid eluates were neutralized
with 100 mM TriszCl, pH 9.4, and dialyzed into PS buffer as
above.
Results
The Class C Vps Proteins Associate with Ypt7p. Membrane traffick-
ing depends on small GTPases of the YptyRab family (33, 34).
For homotypic vacuole fusion in yeast, Ypt7p mediates an early,
reversible stage of vacuole docking that occurs before the pairing
in trans of v- and t-SNAREs (19, 20). Ypt7p effectors for vacuole
fusion have remained elusive until the recent finding that
Vam2pyVps41p and Vam6pyVps39p, two vacuole-associated
proteins, associate in vitro with recombinant Ypt7p in a GTP-
dependent manner (25).
To further characterize the proteins that associate with Ypt7p,
vacuole detergent extracts were incubated with glutathione-
immobilized GST-Ypt7p that had been preloaded with either no
nucleotide, guanosine 59-[g-thio]triphosphate (GTP[gS]; a non-
hydrolyzable analog of GTP), or GDP (Fig. 1). When analyzed
by silver-staining, several polypeptides selectively associated
with GST-Ypt7p:GTP[gS]. Less association was seen with the
GDP or nucleotide-free forms of the fusion protein. Addition-
ally, these polypeptides did not associate with GST-
Ypt1p:GTP[gS], the Rab-like GTPase that functions in vesicle
transport from the endoplasmic reticulum to the Golgi and in an
early intra-Golgi transport step (37). Each of these Ypt7p-
associated polypeptides was excised from preparative gels and
submitted for identification by mass spectroscopy. The largest of
these polypeptides was Vam6p, consistent with previous immu-
noblot analysis (25). Surprisingly, the other four polypeptides
were the class C Vps proteins: Vps11p, Vps16p, Vps18p, and
Vps33p. These four class C Vps proteins were already known to
interact physically as a high-molecular-weight complex and to
have a functional role in multiple vacuole-targeting pathways
(38), but their exact mode of action was not clear. Further, they
had not been implicated in homotypic vacuole fusion, nor were
they known to be Ypt7p effectors. Vps11p and Vps18p are
hydrophilic proteins with C-terminal RING finger zinc-binding
domains that are thought to mediate proteinyprotein interac-
tions (39–41). Vps16p is also a hydrophilic protein, but lacks
known protein motifs or homologies with characterized proteins
(42). Vps33p is a member of the Sec1p family of proteins (43, 44),
which bind and modulate the activity of t-SNAREs (27–29).
Because these proteins associate specifically with the GTP form
of Ypt7 (Fig. 1), they are part of an effector complex for this
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YptyRab protein. Although we have observed Vam2p in this
complex by immunoblot analysis (data not shown), this protein
was not detected here, perhaps because it is more susceptible to
degradation andyor is less abundant. Lower-molecular-weight
proteins submitted for sequencing were breakdown products of
GST-Ypt7p (data not shown).
Vam2y6p and the Class C Vps Proteins Are Part of a Large Complex on
the Vacuole Membrane. To determine whether the class C Vps
proteins are part of the 65S complex that includes Vam2y6p (26)
and the Vam3p and Nyv1p SNAREs (25), vacuole detergent
extracts were fractionated on sucrose velocity gradients and
analyzed by immunoblotting (Fig. 2). Under the conditions of
this gradient analysis, Vam2p and Vam6p (Fig. 2 A) cosediment
with each other, with the 65S marker ferritin (25), and with each
of the class C Vps proteins (Fig. 2B). Priming by ATP and Sec18p
disassembles the 65S Vam2y6p complex to a 38S complex in
parallel with the disassembly of the cis-SNARE complex (13)
and the release of Sec17p (12). As with Vam2y6p (Fig. 2 A), the
four class C Vps proteins shift from 65S to 38S when the vacuoles
are primed (Fig. 2B).
Vam2y6p and the Class C Vps Proteins Are in the Same Complex.
Vam2y6p and the class C Vps proteins are at least partially
localized to vacuoles (25, 26, 36), cofractionate on sucrose
gradients at a high molecular weight (Fig. 2), and are effectors
of Ypt7p (Fig. 1). To test whether they are directly associated
with each other, vacuole detergent extracts were incubated with
Fig. 1. The class C Vps proteins associate with glutathione-immobilized
GST-Ypt7p:GTP[gS]. Frozen BJ3505 vacuoles (300 mg) were diluted to 1.5 ml
with PS buffer (see Materials and Methods) and sedimented (13,000 3 g, 10
min, 4°C). Vacuole pellets were suspended in 500 ml of IP solubilization buffer
[20 mM Hepes, pH 7.4y150 mM NaCly10% glyceroly1% Triton X-100y13
protease inhibitor mixture (PIC; ref. 30)] and incubated on ice for 10 min. After
sedimentation (13,000 3 g, 10 min, 4°C), the solubilized vacuolar supernatant
was transferred to fresh tubes containing GST-Ypt1p (lane 1) or GST-Ypt7p
(lanes 2–4) that had been prebound to 40 ml (packed volume) of glutathione-
Sepharose beads (Amersham Pharmacia) and preloaded with nucleotides (see
below). [Fusion proteins underwent nucleotide exchange before incubation
with the solubilized vacuolar supernatants. Each fusion protein (120 mg) was
mixed by nutation with 40 ml of glutathione-Sepharose beads in 50 mM TriszCl,
pH 8.0, for 20 min at room temperature. Bound material was sedimented
(10,000 3 g, 1 min, 4°C), and the supernatant was decanted. Beads were
incubated (20 min, room temperature) in 500 ml of PS elution buffer (PS buffer
with 2 M NaCl, 20 mM EDTA, 5 mM GDP, 1 mM DTT, and 13 PIC) and then
sedimented and washed four times by resuspension in 1 ml of PS buffer and
sedimentation (10,000 3 g, 1 min, 4°C). Beads with fusion proteins were
incubated (20 min, room temperature) with either 4 mM GTP[gS] (lanes 1 and
3), 4 mM GDP (lane 2), or no nucleotide (lane 4) in 500 ml of PS loading buffer
(PS buffer containing 150 mM KCl, 4.5 mM MgCl2, 0.5 mM MnCl2, 1 mM DTT,
and 13 PIC) and collected (10,000 3 g, 1 min, 4°C).] Detergent extracts of
vacuoles were mixed with beads by nutation for 2 h at 4°C. Unbound material
was decanted from the beads after centrifugation (10,000 3 g, 1 min, 4°C).
Beads were resuspended twice in 1 ml of IP solubilization buffer and sedi-
mented as above, and then bound proteins were eluted with 500 ml of PS
elution buffer. Elution was by nutation for 15 min at room temperature
followed by centrifugation. The eluate was precipitated by 12.5% trichloro-
acetic acid for 15 min on ice followed by centrifugation (13,000 3 g, 15 min,
4°C). The pellet was resuspended in 1 ml of 80% acetone and sedimented as
above. Protein pellets were dried and resuspended in 50 ml SDSyPAGE loading
buffer, and polypeptides were separated on 10% acrylamide gels (35). Visu-
alization was by silver staining (36); mass spectroscopy analysis (at the Howard
Hughes Medical InstituteyKeck Lab, Yale University) was performed on
polypeptides extracted from a similar preparative gel stained with Coomassie
brilliant blue.
Fig. 2. Cofractionation on sucrose velocity gradients of HOPS complex
proteins. Freshly isolated BJ3505 vacuoles (400 mg) were diluted to 1.5 ml with
PS buffer and sedimented (13,000 3 g, 10 min, 4°C). Pellets were resuspended
in 2 ml of either priming mixture [5 mM ATP, 5 mM MgCl2, 1 mgyml creatine
kinase, 100 mM creatine phosphate, 0.13 PIC, and 25 ng of his6-Sec18pymg
vacuolar protein (11)] or priming inhibition mixture (priming mixture, but
with 0.16 units of apyraseymg vacuolar protein substituting for ATP) and
incubated for 10 min at 27°C. Vacuoles then were sedimented as above,
resuspended in 1 ml of PS buffer, and sedimented. Vacuole pellets were
suspended in 400 ml of PS solubilization buffer (PS buffer plus 1% Triton X-100
and 13 PIC) and incubated on ice for 10 min. After centrifugation (13,000 3
g, 10 min, 4°C), the solubilized vacuolar supernatants were loaded on 11.6-ml
continuous (40–10%, wtyvol) sucrose gradients in PS buffer plus 1% Triton
X-100. Samples were centrifuged at 250,000 3 g for 6 h at 4°C (SW 41 rotor;
Beckman). Fractions of 800 ml were collected from the top of the gradient, and
aliquots were separated by SDSyPAGE (10% acrylamide; ref. 35), analyzed by
immunoblotting to the indicated proteins, and quantitated by scanning den-
sitometry. E, 2ATP; F, 1ATP. (A) Vam2p and Vam6p. (B) Vps11p, Vps16p,
Vps18p, and Vps33p.
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protein A-Sepharose-immobilized antibodies to Vam2y6p, to
each of the four class C Vps proteins, or to a control antibody
to the E. coli SecE protein. Immunoprecipitated proteins then
were analyzed by immunoblotting (Fig. 3). In each case, anti-
bodies to Vam2y6p and the class C Vps proteins cross-
immunoprecipitated all six proteins (Fig. 3A, lanes 2–7). The
efficiency of the cross-immunoprecipitations was remarkably
similar to the efficiency with which each antibody immunopre-
cipitated its cognate protein, suggesting that the majority of each
of these proteins exist in a complexed state. The specificity of the
immunoprecipitations is highlighted by the lack of cross-
immunoprecipitation with antibodies to SecE (lane 8) and by the
fact that none of the antibodies immunoprecipitated the vacuole
membrane protein Pho8p. We also addressed the issue of
specificity by using affinity-purified antibodies that had been
prepared to a peptide from the Vps33p sequence. Immunopre-
cipitations were performed in the presence of nonspecific or
specific peptide inhibitors (Fig. 3B). The Vps33p peptide anti-
body was as efficient at immunoprecipitating Vps33p (lanes 1
and 2) as the Vps33p fusion protein antibodies (Fig. 3A, lanes 1
and 7), and the addition of a 3:1 molar excess of SecE peptide
before the addition of the vacuole detergent extract had no effect
(Fig. 3B, lane 2). In contrast, Vps33p peptide efficiently blocked
the immunoprecipitation of both Vps33p and Vam6p (lane 3).
Thus, Vam2y6p and the class C Vps proteins are all part of the
same large, 65S complex on the vacuole membrane (Fig. 3),
which can be disassembled to a 38S subcomplex by priming (Fig.
2), and the proteins thereby can be activated to bind to Ypt7p
(Fig. 1 and ref. 25).
The Class C Vps Proteins Are Needed for Vacuole Fusion. Homotypic
vacuole fusion can be measured in vitro by mixing populations of
purified vacuoles from two yeast strains, one with a deletion of
PHO8 and the other with deletions in vacuole proteases. Vacu-
oles from the first strain have normal proteases but no Pho8p,
whereas vacuoles from the second strain lack proteases and,
therefore, accumulate catalytically inactive pro-Pho8p. Upon
incubation with ATP, these vacuoles undergo priming, docking,
and fusion, allowing the proteases to gain access to the proen-
zyme and process it to its active form, which can be assayed
colorimetrically (30). Using this assay, we found (Fig. 4) that the
reaction is blocked by antibody to each of the four class C Vps
proteins, as shown previously for antibody to Vam2p or Vam6p
(24), but is not blocked by antibody to other Vps proteins such
as Vps45p, Vps17p, and Vps5p. This is consistent with studies
showing that Vps33p is required for in vitro trafficking from the
endosome to the vacuole (46). The sensitivity of the reaction to
antibody to each class C Vps protein as well as to antibody to
Vam2p and Vam6p is in accord with the physical evidence that
they are part of the same complex.
Discussion
The class C vps mutants, selected by their defects in protein
delivery to the vacuole, contain very small, highly fragmented
vacuoles or vacuole-related organelles (7, 8). A visual screen
Fig. 3. Coimmunoprecipitation of HOPS complex subunits. (A) Detergent-
solubilized vacuolar supernatants (500 ml) were prepared from 200 mg of
frozen BJ3505 vacuoles as described in Fig. 1 (lane 1). Each vacuole extract was
mixed by nutation for 2 h at 4°C with 20 ml (packed volume) of protein
A-Sepharose CL-4B beads (Amersham Pharmacia), which had been cross-
linked to affinity-purified antibodies to Vam2p (lane 2), Vam6p (lane 3),
Vps11p (lane 4), Vps16p (lane 5), Vps18p (lane 6), Vps33p (lane 7), or IgG
antibodies to E. coli SecE (lane 8). [Before mixing, beads were mock-eluted
with 200 ml of 1% (wtyvol) SDS at 37°C for 10 min followed by sedimentation
(10,000 3 g, 1 min, 4°C). Beads were washed three times in 500 ml of IP
solubilization buffer and then preblocked by a 15-min nutation in 500 ml of IP
solubilization buffer containing 2% (wtyvol) BSA (Fraction V; Sigma). Beads
were sedimented (10,000 3 g, 1 min, 4°C) and then suspended twice in 500 ml
of IP solubilization buffer and sedimented.] Beads were collected by sedimen-
tation (10,000 3 g, 1 min, 4°C) and washed two times by resuspension in 1 ml
of IP solubilization buffer and sedimentation. Bound proteins were eluted
with 200 ml of 1% (wtyvol) SDS as above. After sedimentation (10,000 3 g, 1
min, 4°C) to remove beads, 180 ml of the eluate was supplemented with 45 ml
of 53 SDSyPAGE loading buffer (45). Proteins were analyzed by SDSyPAGE
(10% acrylamide) and immunoblotting. (B) Immunoprecipitations were as
described in A, except that the antibodies were to Vps33p peptides (see
Materials and Methods). After incubating the beads in IP solubilization buffer
plus 2% (wtyvol) BSA and before mixing with vacuole detergent extracts, the
beads were mixed with a 3:1 molar excess of either SecE peptide (ATV AFA REA
ATE VRK VIW PTR QET C; SecE, lane 2) or Vps33 peptides (Vps33p, lane 3) for
1 h at room temperature.
Fig. 4. Antibody to each of the class C Vps proteins inhibits homotypic
vacuole fusion. Homotypic vacuole fusion was assayed as described (30) but
without cytosol. Before the preparation of the fusion assay mix, each vacuole
population was incubated with 0.05 mgyml affinity-purified antibodies either
to the class C Vps proteins (Vps11p, Vps16p, Vps18p, and Vps33p), other Vps
proteins (Vps5p, Vps17p, and Vps45p), or hemagglutinin (HA; epitope 12CA5).
A separate reaction was treated with 60 mgyml Gdi1p as a control for complete
inhibition of fusion. One unit (U) of alkaline phosphatase activity produces 1
mmol of p-nitrophenolymin per mg BJ3505 vacuolar protein.
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for mutants with such an altered vacuole morphology yielded
the same four genes: VAM1yVPS11, VAM5yVPS33, VAM8y
VPS18, and VAM9yVPS16 (6). We now report that these four
encoded proteins, together with those encoded by VAM2y
VPS41 and VAM6yVPS39, are part of a large HOPS complex
that is essential for homotypic vacuole fusion and vacuole
protein sorting. The HOPS complex initially is part of a larger
65S complex that includes the vacuolar SNAREs Vam3p and
Nyv1p, thereby providing a biochemical explanation for the
known genetic interactions between VPS33 and VAM3 (47).
This 65S complex is disassembled by the action of Sec18p and
Sec17p, and the released 38S HOPS subcomplex binds spe-
cifically to the active GTP-bound form of Ypt7p to initiate
docking.
The Sec1p family of proteins are known to associate specifi-
cally with t-SNAREs and to modulate their conformations and
associations with other SNAREs (27–29). Our current findings
demonstrate that a Sec1p family member, Vps33p, is a subunit
of a YptyRab effector complex, i.e., the HOPS complex. These
findings cast the studies of Price et al. (25) in a new light, because
the presence of Vps33p offers a plausible mechanism for how
this complex can be associated in a 65S complex with SNAREs
and why priming is needed to release HOPS from the 65S
complex and allow association with the GTP-bound form of
Ypt7p.
How can the HOPS complex be needed for both homotypic
vacuole fusion and for protein delivery to the vacuole? In
addition to its function on the vacuole, Vam2yVps41p also
functions on the Golgi in the formation of transport vesicles
destined for the endosome (48). It is possible that the other
members of HOPS also have a function at the Golgi in initiating
trafficking to the endosome. Our current functional biochemical
studies of vacuole fusion by using purified wild-type vacuoles
(Fig. 4), as well as the sequential physical association of the
HOPS complex with vacuolar SNAREs (24, 25) and Ypt7p (Fig.
1), establish that the HOPS complex has a direct role in
homotypic vacuole fusion.
No specific function has been attributed to the HOPS com-
plex, but it is needed until the vacuoles dock. For example,
Vam2p and Vam6p antibodies inhibit vacuole fusion at the same
stage as Gdi1p, a protein that extracts the GDP form of Ypt7p
from the vacuole membrane (25). Antibodies to the class C Vps
proteins also inhibit at this stage (data not shown). The HOPS
complex binds to GST-Ypt7p:GTP[gS] (Fig. 1 and ref. 25) and
thus serves as a Ypt7p effector. The interactions of HOPS
complex proteins and Ypt7p may occur during the early ‘‘teth-
ering’’ step of docking, when vacuoles become loosely and
reversibly associated, before the trans-pairing of SNARE pro-
teins across apposed vacuoles. This model is in accord with the
proposed function of other large complexes that function with
RabyYpt proteins to tether vesicles in other intracellular trans-
port pathways (49). These tethering factors, which may include
the Exocyst for Golgi-to-plasma membrane traffic (50), Uso1p
and TRAPP for endoplasmic reticulum-to-Golgi traffic (51, 52),
EEA1 and Rabaptin-5 for endosome homotypic fusion (53),
p115, giantin, and GM130 for intra-Golgi traffic (54), and Vac1p
for Golgi-to-endosome traffic (55, 56), exhibit some notable
relationships with the HOPS complex. Vam2p and Vam6p are
high-molecular-weight proteins and, like p115 and Uso1p, could
extend out from membrane surfaces to aid in vesicleytarget
tethering. Localization studies of green fluorescent protein-
Vam6p (26) and green fluorescent protein-Vps33p (57) suggest
positioning at a few discrete sites on the vacuole membrane,
which may dictate, like the Exocyst, a locus for docking and
fusion. The HOPS complex also contains Vps33p, one of several
Sec1p homologs that are known to modulate the activity of
t-SNAREs. Like the HOPS complex, Vac1p also interacts with
both a YptyRab protein, Vps21p, and a Sec1p homolog, Vps45p
(55, 56). Together, these complexes may provide an important
functional link between activated Rab proteins and SNAREs,
although in no case other than the HOPS complex has the Sec1p
homolog been shown to be part of a complex that binds directly
to the YptyRab protein. Additionally, in the case of homotypic
vacuole fusion, the order of associations and their causal rela-
tionships now have been delineated. This novel order of inter-
actions, proceeding from (cis) SNAREs to the RabyYpt protein,
raises the intriguing question of whether Ypt7:GTP:HOPS then
interacts directly with SNAREs to catalyze trans-assembly of
SNARE pairs (19).
Although the function of each HOPS complex subunit in
homotypic vacuole fusion is unknown, the functions of several
class C Vps proteins have been studied relative to other vacuole-
sorting pathways. Both Vps11p and Vps18p contain C-terminal
RING finger zinc-binding domains with important roles in
biosynthetic, endocytic, and autophagic vacuole-targeting path-
ways (38). It will be important to determine whether these HOPS
complex subunits perform similar functions to support homo-
typic fusion as they do for heterotypic-trafficking reactions.
There are four Sec1p homologs in yeast (Sec1p, Sly1p, Vps33p,
and Vps45p), and each may regulate the docking of vesicles to
their respective targets through interactions with t-SNAREs.
Vps33p, however, is unusual among the Sec1p-like proteins in
that it contains an ATP-binding cassette. This cassette appears
to be indispensable for Vps33p function because a point muta-
tion in this region leads to a class C vps phenotype (43) and a
partial deletion of the cassette impairs the proper targeting and
processing of carboxypeptidase Y (57). Both the integrity of this
ATP-binding cassette as well as cellular ATP levels govern the
distribution of Vps33p between the cytosol and perivacuolar
spots (57). These perivacuolar spots may be the same as those
visualized for Vam6p (26) and may represent the HOPS complex
on the vacuole surface. Previous studies have shown that the
release of Vam2p and Vam6p from primed vacuoles depends on
ATP after the priming step (25). Perhaps ATP binding by
Vps33p governs the localization of the entire complex. It is
noteworthy that Vps11p also contains an ATP-binding cassette,
although its functionality has not been fully tested. Finally, there
is a dynamic interaction among the class C Vps proteins by which
Vps16p links the association of Vps33p to Vps11p and Vps18p
(38). These interactions and their relationship to Vam2y6p may
be important to the function of the complex as a whole.
It appears that the activity of HOPS complex proteins could
be conserved in similar vesicle-trafficking pathways of other
organisms. Indeed, homologs of VAM2 and VPS33 can be
identified from plants to mammals (58, 59). VAM2, VPS18, and
VPS33 also have been identified in Drosophila as the eye
pigmentation mutants light (lt), deep orange (dor), and carna-
tion (car), respectively (45, 60, 61). Genetic studies have
revealed an association of lt and dor (61) whereas a high-
molecular-weight complex containing Dor and Car has been
shown to associate with endosomal membranes (45), as in yeast
(ref. 38; this study). Further molecular characterization of
these mutants indicates defects in the biogenesis of the pig-
mentation granule, a compartment related to the vacuoley
lysosome (45). It will be of interest to determine whether these
proteins function specifically in the docking and fusion of
vesicles to this lysosomal compartment, as in yeast homotypic
vacuole fusion.
Further progress in understanding the functions of the HOPS
complex in yeast will require its purification to homogeneity and
the identification of each of its subunit polypeptides. In addition,
it will be vital to establish a functional assay for the HOPS
complex; the demonstration that it can bind GST-
Ypt7p:GTP[gS] may be a first step toward such a reconstitution
of function.
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